GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Rhinomed Ltd (ASX:RNO) » Definitions » Cash Receipts from Fees and Commissions

Rhinomed (ASX:RNO) Cash Receipts from Fees and Commissions


View and export this data going back to 2007. Start your Free Trial

What is Rhinomed Cash Receipts from Fees and Commissions?

Cash Receipts from Fees and Commissions only applies to banks.


Rhinomed (ASX:RNO) Business Description

Industry
Traded in Other Exchanges
Address
132 Gwynne Street, Level 1, Cremorne, VIC, AUS, 3121
Rhinomed Ltd is a medical technology company, with a patented nasal technology platform. It is engaged in the research, development and commercialization of consumer and medical devices including nasal, respiratory and nasal drug delivery technologies. It operates in one segment which is the identification, acquisition, and commercialization of late-stage consumer therapeutic and medical delivery technologies. The products of the company involve Rhinoswab, Mute, Turbine and Rhinoswab Junior. It operates geographically within North, Central, and South America, Asia-Pacific, Europe, Middle East, and Africa. The company earns majority of its revenue from Asia-Pacific.